Launch Date: May 1, 2025
Expiration Date: May 1, 2026

To claim 1.0 AMA PRA Category 1 Credit™ for this activity, please visit: Peds GI Connect News: A CME Proceedings Newsletter for Pediatric Gastroenterology Providers | HCP Education Portal

Target Audience

This activity has been designed to meet the educational needs of pediatric gastroenterologists and other healthcare providers involved in the care of patients with Gi disorders.

Goal Statement

The goal of this program is to help pediatric gastroenterologists and healthcare providers stay up-to-date with the latest treatments and diagnostic tools for common GI disorders in children. By learning about new advancements, participants will be better prepared to improve the care and outcomes of their young patients.

Learning Objectives

After completing this activity, participant should be able to:

• Describe evolving management strategies for pediatric patients with common GI disorders
• Integrate significant advances in therapeutic and diagnostic modalities for pediatric GI disorders into clinical practice

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and the Gi Health Foundation (GiHF). The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relevant Financial Relationships:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24 months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify from involvement in the planning and implementation of accredited continuing education any individuals (1) who refuse to provide this information or (2) whose conflicts of interests cannot be mitigated.

*Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant relationships have been mitigated prior to the commencement of this activity.

All additional planning committee members, the University of Cincinnati staff and the Gi Health Foundation (GiHF) staff have no relationships to disclose.

Disclaimer:

The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees' professional development.

Off-Label Disclosure Statement:

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

Fee information:There is no fee for this online educational activity.

Jointly provided by the University of Cincinnati and the GIHF.

Supported by educational grants from Janssen Biotech, Inc., and Reckitt/Mead Johnson Nutrition.